Trinity Biotech plc (TRIB) is a publicly traded Healthcare sector company. As of May 21, 2026, TRIB trades at $0.59 with a market cap of $11.54M and a P/E ratio of 0.00. TRIB moved +6.65% today. Year to date, TRIB is -20.85%; over the trailing twelve months it is -25.11%. Its 52-week range spans $0.48 to $3.44. Rallies surfaces TRIB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded TRIB stock?
Rallies tracks politician and congressional stock disclosures for TRIB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 17.80K (~$924.52K) on Feb 18, 2004.
ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 92.00K (~$4.82M) on Feb 17, 2004.
ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 65.20K (~$3.39M) on Feb 13, 2004.
TRIB Analyst Consensus
TRIB analyst coverage data. Average price target: $0.00.
Common questions about TRIB
Which politicians traded TRIB stock?
Rallies tracks politician and congressional stock disclosures for TRIB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in TRIB?
Yes. Rallies tracks politician and congressional stock disclosures for TRIB, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TRIB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TRIB. It does not provide personalized investment advice.
